Medicamentos inovadores: o caminho para a definição de preços 💰 #212

O Brasil pode, enfim, concluir a atualização das regras da Câmara de Regulação do Mercado de Medicamentos (CMED), após anos de debates sobre como garantir preços justos e acesso à inovação.No novo episódio do Biotech and Health, Laura Murta e Camila Pepe recebem Pedro Bernardo, ex-secretário-executivo da CMED. Ele relembra o histórico da Resolução nº 2/2004 e analisa os avanços, os riscos e os desafios da proposta atualmente em consulta pública.

Episode metadata supplied by the publisher feed · Published Jul 3, 2025

Embed this episode

Attribution link and audio player

Ready to play

Medicamentos inovadores: o caminho para a definição de preços 💰 #212

0:00 37:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MIT Technology Review Brasil?

This episode is 37 minutes long.

When was this MIT Technology Review Brasil episode published?

This episode was published on July 3, 2025.

Can I download this MIT Technology Review Brasil episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!